Universidad El Bosque, El Bosque Research Group of Maternal Fetal, Medicine and Gynecology, Ecodiagnóstico El Bosque SAS, Los Cobos Medical Center, Bogotá, Colombia.
Research Group Community Medicine and Collective Health, El Bosque University, Los Cobos Medical Center, Bogotá, Colombia.
Rev Bras Ginecol Obstet. 2022 Mar;44(3):231-237. doi: 10.1055/s-0042-1742411. Epub 2022 Feb 9.
To analyze whether acetylsalicylic (ASA) intake modifies the mean uterine arteries pulsatility index (UtA-PI) at the 2 or 3 trimester in a cohort of pregnant women with abnormal mean UtA-PI at between 11 and 14 weeks of gestation.
This is a retrospective cohort study. Singleton pregnancies with abnormal mean UtA-PI at between 11 and 14 weeks of gestation were studied. The participants were divided into 3 groups: 1) If the participant did not take ASA during pregnancy; 2) If the participant took ASA before 14 weeks of gestation; and 3) If the participant took ASA after 14 weeks of gestation. The mean UtA-PI was evaluated at the 2 and 3 trimesters, and it was considered to improve when it decreased below the 95 percentile. The prevalence ratio (PR) and the number needed to treat (NNT) were calculated.
A total of 72 participants with a mean UtA-PI > 95 percentile at the 1 trimester of gestation were evaluated. Out of the 18 participants who took ASA, 8 participants started it before 14 weeks of gestation and 10 after. A total of 33.3% of these participants had improved the mean UtA-PI at the 2 and 3 trimesters of gestation, although it was not statistically significant ( = 0.154). The prevalence ratio was 0.95 (95% confidence interval [CI]: 0.31-1.89), but between the 1 and 2 trimesters of gestation, the PR was 0.92 (95%CI: 0.21-0.99) and it was statistically significant.
The present work demonstrates a modification of the mean UtA-PI in participants who took ASA compared with those who did not. It is important to check if ASA can modify the normal limits of uterine arteries because this could have an impact on surveillance.
分析在 11 至 14 孕周期间平均子宫动脉搏动指数(UtA-PI)异常的孕妇队列中,乙酰水杨酸(ASA)的摄入是否会改变 2 或 3 孕期的平均 UtA-PI。
这是一项回顾性队列研究。研究了在 11 至 14 孕周期间平均 UtA-PI 异常的单胎妊娠。将参与者分为 3 组:1)如果参与者在怀孕期间未服用 ASA;2)如果参与者在 14 孕周之前服用 ASA;3)如果参与者在 14 孕周后服用 ASA。在 2 至 3 孕期评估平均 UtA-PI,并认为当它降低到第 95 百分位以下时会有所改善。计算了患病率比(PR)和需要治疗的人数(NNT)。
共评估了 72 名在 1 孕期平均 UtA-PI>第 95 百分位的参与者。在服用 ASA 的 18 名参与者中,有 8 名在 14 孕周之前开始服用,10 名在之后开始服用。尽管这在统计学上并不显著( = 0.154),但这些参与者中有 33.3%在 2 和 3 孕期的平均 UtA-PI 有所改善。患病率比为 0.95(95%置信区间 [CI]:0.31-1.89),但在 1 至 2 孕期,PR 为 0.92(95%CI:0.21-0.99),且具有统计学意义。
本研究表明,与未服用 ASA 的参与者相比,服用 ASA 的参与者的平均 UtA-PI 有所改变。检查 ASA 是否可以改变子宫动脉的正常范围很重要,因为这可能会对监测产生影响。